Abstract
Dissemination of tumor cells includes several steps, such as: (a) detachment of tumor cells from the primary tumor, (b) traversement of the basement membrane, and (c) migration into the extracellular matrix. In these processes, at least two important categories of proteins are involved: proteases and adhesion molecules. In this contribution we describe the expression and function of components of the plasminogen activator (PA) system (proteases) and of integrins (cell-matrix adhesion molecules) in a panel of four human melanoma cell lines with different invasive and metastatic capacity. Regarding the components of the PA system, we found differences in expression of urokinase-type PA (uPA) and type 1 and 2 PA inhibitors (PAI-1 and -2) between metastasizing and nonmetastasizing cell lines. Both components were exclusively expressed in the highly invasive and metastatic cell lines. Interestingly, studies on the expression of PA components in fresh human melanocytic lesions, showed expression of these components exclusively in advanced primary melanomas and melanoma metastases. Regarding integrin expression we found elevated levels of VLA-2 and VLA-6 in the highly invasive and metastatic cell lines compared with normal cultured melanocytes and nonmetastatic melanoma cell lines. In addition, increased adhesion of the highly metastatic cell lines to laminin (LM) and collagen (COLL) was observed. Furthermore, reduced adhesion of normal melanocytes and nonmetastatic melanoma cells to LM and CO was mainly due to the fact that the integrins involved in adhesion to these matrix components were present in an inactive state. Finally, differences were observed in expression of integrins involved in adhesion to fibronectin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Albelda SM (1993) Biology of disease: role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68:4–17
Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck C (1990) Integrin distribution in malignant melanoma: association of the β 3 subunit with tumor progression. Cancer Res 50:6757–6764
Bastida E (1988) The metastatic cascade: potential approaches for the inhibition of metastasis. Semin Thromb Hemost 14:66–72
Bröcker E-B, Suter L, Brüggen J, Ruiter DJ, Macher E, Sorg C (1985) Phenotype dynamics of tumor progression in human malignant melanoma. Int J Cancer 36:29–35
Chan BMC, Matsuura N, Takada Y, Zetter BR, Hemler ME (1991) In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 251:1600–1602
Clark WH Jr, Elder DE, Guerry D, Epstein MN, Greene MH, van Horn M (1984) A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15:1147–1156
Danen EHJ, van Muijen GNP, van de Wiel-van Kemenade E, Jansen CFJ, Ruiter DJ, Figdor CG (1993) Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells. Int J Cancer 54:315–321
Danen EHJ, ten Berge PJM, van Muijen GNP, van’t Hof-Grootenboer AE, Bröcker E-B, Ruiter DJ (1994a) Emergence of α 5 β 1 fibronectin- and α v β 3 vitronectin receptor expression in melanocytic tumor progression. Histopathology (in press)
Danen EHJ, Jansen CFJ, Ruiter DJ, van Muijen GNP (1994b) Expression of αv- integrins in human cutaneous melanoma: decreased expression of α v β 5 during melanoma progression (submitted)
Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139–266
De Vries TJ, Quax PHA, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, van Muijen GNP (1994) Plasminogen activators, their inhibitors and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144:71–80
Felding-Habermann B, Mueller BM, Romerdahl CA, Cheresh DA (1992) Involvement of integrin αv gene expression in human melanoma tumorigenicity. J Clin Invest 89:2018–2022
Fidler IJ (1989) Origin and biology of cancer metastasis. Cytometry 10:673–680
Gehlsen KR, Davis GE, Sriramarao P (1992) Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 10:111–120
Giancotti FG, Ruoslahti E (1990) Elevated levels of the α 5 β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60: 849–859
Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H (1987) Biology of disease: biology of tumor progression in human melanocytes. Lab Invest 56:461–474
Juliano RL (1987) Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochem Biophys Acta 907: 261–278
Juliano RL, Haskill S (1993) Signal transduction from the extracellular matrix. J Cell Biol 120:577–585
Klein CE, Steinmeyer T, Kaufmann R, Weber L, Bröcker E-B (1991) Identification of a melanoma progression antigen as integrin VLA-2. J Invest Dermatol 96: 281–284
Liotta LA, Rao CN, Barsky SH (1983) Tumor invasion and extracellular matrix. Lab Invest 49:636–649
Marshall JF, Nesbitt SA, Helfrich MH, Horton MA, Polakova K, Hart IR (1991) Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer 49:924–931
Mignatti P, Rifkin DB (1993) Biology and biochemistry op proteinases in tumor invasion. Physiol Rev 73:161–195
Mignatti P, Robbins E, Rifkin DB (1986) Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47:487–498
Mortarini R, Anichini A (1993) From adhesion to signalling: roles of integrins in the biology of human melanoma. Melanoma Res 3:87–97
Mortarini R, Gismondi A, Santoni A, Parmiani G, Anichini A (1992) Role of the α 5 β 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin. Cancer Res 52:4499–4506
Natali PG, Nicotra MR, Cavaliere R, Giannarelli D, Bigotti A (1991) Tumor progression in human malignant melanoma is associated with changes in α 6 β 1 laminin receptor. Int J Cancer 49:168–172
Natali PG, Nicotra MR, Bartolazzi A, Cavaliere R, Bigotti A (1993) Integrin expression in cutaneous malignant melanoma: association of the α 3 β 1 heterodimer with tumor progression. Int J Cancer 54:68–72
Paulus W, Baur I, Schuppan D, Roggendorf W (1993) Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 143:154–163
Pöllänen J, Stephens RW, Vaheri A (1991) Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 50:273–328
Quax PHA, Leeuwen RTJ, Verspaget HW, Verheijen JH (1990) Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines. Cancer Res 50:1488–1494
Quax PHA, van Muijen GNP, Weening-Verhoeff EJD, Lund LR, Dano K, Ruiter DJ, Verheijen JH (1991) Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol 115:191–199
Schwartz MA (1993) Signaling by integrins: implications for tumorigenesis. Cancer Res 53:1503–1506
Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslathi E, Hendrix MJC (1992) Role of the α v β 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 89:1557–1561
Seftor REB, Seftor EA, Stetler-Stevenson WG, Hendrix MJC (1993) The 72kDa type IV collagenase is modulated via differential expression of α v β 3 and α 5 β 1 integrins during human melanoma cell invasion. Cancer Res 53:3411–3415
Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9:289–303
Van de Wiel-van Kemenade E, van Kooyk Y, de Boer AJ, Huijbens RJF, Weder P, van de Kasteele W, Melief CJM, Figdor CG (1992) Adhesion of T and B lymphocytes to extracellular matrix and endothelial cells can be regulated through the β subunit of VLA. J Cell Biol 117:461–470
Van Kooyk Y, van de Wiel-van Kemenade P, Weber P, Kuijpers TW, Figdor CG (1989) Enchancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 342:811–813
Van Muijen GNP, Coraelissen IMHA, Jansen CFJ, Ruiter DJ (1989) Progression markers in metastasizing human melanoma cells xenografted to nude mice. Anticancer Res 9:879–884
Van Muijen GNP, Cornelissen IMHA, Jansen CFJ, Figdor CG, Johnson JP, Bröcker E-B, Ruiter DJ (1991a) Antigen expression of metastasizing and nonmetastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis 9:259–272
Van Muijen GNP, Jansen CFJ, Cornelissen IMHA, Smeets DFCM, Beck JLM, Ruiter DJ (1991b) Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 48:85–91
Wilkins JA, Stupack D, Stewart S, Caixia S (1991) β 1 Integrin mediated lymphocyte adherence to extracellular matrix is enchanced by phorbol ester treatment. Eur J Immunol 21:517–522
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
van Muijen, G.N.P., Danen, E.H.J., de Vries, T.J., Quax, P.H.A., Verheijen, J.H., Ruiter, D.J. (1995). Properties of Metastasizing and Nonmetastasizing Human Melanoma Cells. In: Garbe, C., Schmitz, S., Orfanos, C.E. (eds) Skin Cancer: Basic Science, Clinical Research and Treatment. Recent Results in Cancer Research, vol 139. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78771-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-78771-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78773-7
Online ISBN: 978-3-642-78771-3
eBook Packages: Springer Book Archive